BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 198654)

  • 1. Paradoxical ACTH response to glucocorticoids in Cushing's disease.
    Fehm HL; Voight KH; Lang RE; Beinert KE; Kummer GW; Pfeiffer EF
    N Engl J Med; 1977 Oct; 297(17):904-7. PubMed ID: 198654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive rate-sensitive corticosteroid feedback mechanism of ACTH secretion in Cushing's disease.
    Fehm HL; Voigt KH; Kummer G; Pfeiffer EF
    J Clin Invest; 1979 Jul; 64(1):102-8. PubMed ID: 221540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease.
    Lankford HV; Tucker HS; Blackard WG
    N Engl J Med; 1981 Nov; 305(21):1244-8. PubMed ID: 6270557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hydrocortisone on ACTH, growth hormone, insulin and glucose in the blood of bilaterally adrenalectomized patients.
    Kasperlik-Zaluska AA; Migdalska B; Wilczyńska J; Krassowski J
    Horm Metab Res; 1980 Dec; 12(12):676-9. PubMed ID: 6259040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
    Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F
    J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma ACTH responses to cortisol infusion are similar in patients with primary hypoadrenalism and patients studied some years after bilateral adrenalectomy for Cushing's syndrome.
    Atkinson AB; Beacom R; Kennedy AL; Hadden DR; Sheridan B
    Clin Endocrinol (Oxf); 1989 May; 30(5):581-6. PubMed ID: 2557986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of adrenocorticotropin (ACTH) precursors in post-adrenalectomy Cushing's disease and their regulation by glucocorticoids.
    Ray DW; Gibson S; Crosby SR; Davies D; Davis JR; White A
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2430-6. PubMed ID: 7629238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
    Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
    Streeten DH; Anderson GH; Brennan S; Jones C
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma immunoassayable ACTH levels during and after hydrocortisone infusion in patients with Cushing's disease.
    Hashimoto K; Takahara J; Hosogi H; Yunoki S; Ofuji T
    Endocrinol Jpn; 1976 Jun; 23(3):243-9. PubMed ID: 186258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma testosterone profiles in Cushing's syndrome.
    Smals AG; Kloppenborg PW; Benraad TJ
    J Clin Endocrinol Metab; 1977 Aug; 45(2):240-5. PubMed ID: 195973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE; McKenzie AK
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects.
    Roelfsema F; Pincus SM; Veldhuis JD
    J Clin Endocrinol Metab; 1998 Feb; 83(2):688-92. PubMed ID: 9467594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nyctohemeral variation and suppressibility of plasma ACTH in various stages of Cushing's disease.
    Cook DM; Kendall JW; Allen JP; Lagerquist LG
    Clin Endocrinol (Oxf); 1976 Jul; 5(4):303-12. PubMed ID: 183922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassayable ACTH in dexamethasone nonsuppressible Cushing's syndrome.
    Rayyis SS; Bethune JE
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1231-7. PubMed ID: 4309156
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothalamic abnormalities in patients with pituitary-dependent Cushing's syndrome.
    Stewart PM; Penn R; Gibson R; Holder R; Parton A; Ratcliffe JG; London DR
    Clin Endocrinol (Oxf); 1992 May; 36(5):453-8. PubMed ID: 1319858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.